Age at onset and long-term metabolic control affect height in type-1 diabetes mellitus

被引:0
|
作者
R. W. Holl
M. Grabert
E. Heinze
W. Sorgo
K. M. Debatin
机构
[1] Department of Paediatrics,
[2] University Children's Hospital,undefined
[3] Prittwitzstrasse 43,undefined
[4] D-89075 ulm,undefined
[5] 43,undefined
[6] Germany,undefined
来源
关键词
Keywords Insulin-dependent diabetes mellitus; Height; Metabolic control; Glycosylated haemoglobin;
D O I
暂无
中图分类号
学科分类号
摘要
Reduced height as a consequence of type-I-diabetes mellitus in childhood has been reported in many studies. However, it is still debated whether good metabolic control can normalize the growth rate. A total of 436 children (204 boys, 232 girls, mean age at diagnosis of diabetes 8.2±0.2 years) were followed at our outpatient diabetes centre. Z-scores for height were evaluated in relation to duration of diabetes, age at onset and long-term metabolic control. At diagnosis, height in children with diabetes was significantly above the reference population (+0.43± 0.09). Standardized height decreased during the subsequent course of diabetes. This likely represents a delay of growth, as the final height (chronological age >18 years, n = 144) was +0.27 ± 0.09. Growth reduction was more pronounced in patients diagnosed before the onset of puberty and final height in patients with a prepubertal onset of diabetes was significantly lower (+0.10 ± 0.13) compared to patients with a pubertal/postpubertal onset (+0.52 ± 0.14). Among patients with a prepubertal onset, the subgroup with “poor” metabolic control (long-term median HbA1c >7%) lost significantly more height compared to patients with “good” metabolic control.
引用
收藏
页码:972 / 977
页数:5
相关论文
共 50 条
  • [31] Metabolic Control Improves Long-Term Renal Allograft and Patient Survival in Type 1 Diabetes
    Morath, Christian
    Zeier, Martin
    Doehler, Bernd
    Schmidt, Jan
    Nawroth, Peter P.
    Opelz, Gerhard
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2008, 19 (08): : 1557 - 1563
  • [32] AGE AT ONSET OF TYPE-1 DIABETES IS GENETICALLY-DETERMINED
    FAVA, D
    ROWE, R
    PYKE, DA
    LESLIE, RDG
    DIABETOLOGIA, 1995, 38 : A29 - A29
  • [33] The influence of treatment, age at onset, and metabolic control on height in children and adolescents with type 1 diabetes-A SWEET collaborative study
    Svensson, Jannet
    Schwandt, Anke
    Pacaud, Daniele
    Beltrand, Jacques
    Birkebaek, Niels H.
    Cardona-Hernandez, Roque
    Casteels, Kristina
    Castro, Sofia
    Cherubini, Valentino
    Cody, Declan
    Fisch, Naama
    Hasnani, Dhruvi
    Kordonouri, Olga
    Kosteria, Ioanna
    Luczay, Andrea
    Pundziute-Lycka, Auste
    Maffeis, Claudio
    Piccini, Barbara
    Luxmi, Poran
    Sumnik, Zdenek
    de Beaufort, Carine
    PEDIATRIC DIABETES, 2018, 19 (08) : 1441 - 1450
  • [34] GROWTH REDUCTION AND METABOLIC CONTROL IN TYPE-1 DIABETES
    THON, A
    BREMER, J
    ENDRES, W
    HEINZE, E
    KOLETZKO, S
    NOTHJUNGE, J
    SCHMID, H
    MONATSSCHRIFT KINDERHEILKUNDE, 1984, 132 (09) : 747 - 747
  • [35] Gastric emptying of solid and liquid meals in healthy controls compared with long-term type-1 diabetes mellitus under optimal glucose control
    Folwaczny, C
    Wawarta, R
    Otto, B
    Friedrich, S
    Landgraf, R
    Riepl, RL
    EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES, 2003, 111 (04) : 223 - 229
  • [36] The effect of resistance versus aerobic training on metabolic control in patients with type-1 diabetes mellitus
    Ramalho, Ana Claudia
    Lima, Maria de Lourdes
    Nunes, Fabiana
    Cambui, Zanine
    Barbosa, Cynara
    Andrade, Aline
    Viana, Adriana
    Martins, Marlene
    Abrantes, Valter
    Aragao, Cresio
    Temistocles, Marcos
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2006, 72 (03) : 271 - 276
  • [37] THE IMPACT OF METABOLIC CONTROL ON THE EXCRETION OF TUBULAR MARKERS IN PATIENTS WITH TYPE-1 DIABETES-MELLITUS
    JUNGMANN, E
    GALETTE, A
    HOPFENMULLER, B
    SCHERBERLCH, J
    USADEL, KH
    KIDNEY INTERNATIONAL, 1992, 41 (02) : 486 - 486
  • [38] METABOLIC CONTROL AND ITS INFLUENCE ON PLATELET AND COAGULATION ABNORMALITIES IN TYPE-1 DIABETES-MELLITUS
    BAKER, RI
    PITNEY, WR
    ROHL, P
    CHESTERMAN, CN
    THROMBOSIS AND HAEMOSTASIS, 1985, 54 (01) : 72 - 72
  • [39] Clinical value of serum fructosamine determinations in monitoring metabolic control in type-1 diabetes mellitus
    Guevara-Aguirre, Jaime
    Vidgen, Edward A.
    Guevara-Aguirre, Marco
    Saavedra, Jeannette
    Rosenbloom, Arlan
    Bernstein, Gerald
    DIABETES, 2008, 57 : A546 - A546
  • [40] LONG-TERM CONTROL OF DIABETES-MELLITUS AND PERIODONTITIS
    TERVONEN, T
    OLIVER, RC
    JOURNAL OF CLINICAL PERIODONTOLOGY, 1993, 20 (06) : 431 - 435